TAVI in 2025: transforming care with the new valvular heart disease guidelines

Sponsored by Edwards Lifesciences
TAVI
Symposium with LIVE case
Edwards Lifesciences
Main Arena

Anchorperson: Christopher Cook

Spokesperson: Martin Leon

Operators: Sabine Bleiziffer, Tanja Rudolph

Procedural Analyst: Radoslaw Parma

Discussants: Philippe Genereux, Kentaro Hayashida, Philippe Pibarot, Ferdinand Vogt

Onstage Medical Coordinator: Omar Chehab

Cathlab Medical Coordinator: Mohammad Kassar

Watch this session if you want

  • To understand how the 2025 valvular heart disease guidelines are reshaping TAVI care and clinical decision-making
  • To engage with the paradigm shift in the contemporary management of severe aortic stenosis
  • To gain a global perspective on addressing the challenges of an expanding TAVI population
Welcome and session objectives

Christopher Cook

Patient presentation and headline updates from VHD guidelines

Philippe Genereux

Heart team discussion
LIVE Case procedure
Case debrief

 

Procedural analysis

Radoslaw Parma

Discussion and audience interaction
International multidisciplinary perspective on early referral, simplified evaluation, and prompt treatment of patients with aortic stenosis

Philippe Pibarot

Discussion and audience interaction
Session evaluation and key learnings

 

Suggested videos